IBDEI1VH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29911,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Unspec
 ;;^UTILITY(U,$J,358.3,29911,1,4,0)
 ;;=4^F31.60
 ;;^UTILITY(U,$J,358.3,29911,2)
 ;;=^5003505
 ;;^UTILITY(U,$J,358.3,29912,0)
 ;;=F31.61^^120^1517^5
 ;;^UTILITY(U,$J,358.3,29912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29912,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Mild
 ;;^UTILITY(U,$J,358.3,29912,1,4,0)
 ;;=4^F31.61
 ;;^UTILITY(U,$J,358.3,29912,2)
 ;;=^5003506
 ;;^UTILITY(U,$J,358.3,29913,0)
 ;;=F31.62^^120^1517^6
 ;;^UTILITY(U,$J,358.3,29913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29913,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Moderate
 ;;^UTILITY(U,$J,358.3,29913,1,4,0)
 ;;=4^F31.62
 ;;^UTILITY(U,$J,358.3,29913,2)
 ;;=^5003507
 ;;^UTILITY(U,$J,358.3,29914,0)
 ;;=F31.63^^120^1517^7
 ;;^UTILITY(U,$J,358.3,29914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29914,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Severe w/o Psychotic Feat
 ;;^UTILITY(U,$J,358.3,29914,1,4,0)
 ;;=4^F31.63
 ;;^UTILITY(U,$J,358.3,29914,2)
 ;;=^5003508
 ;;^UTILITY(U,$J,358.3,29915,0)
 ;;=F31.64^^120^1517^8
 ;;^UTILITY(U,$J,358.3,29915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29915,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Severe w/ Psychotic Feat
 ;;^UTILITY(U,$J,358.3,29915,1,4,0)
 ;;=4^F31.64
 ;;^UTILITY(U,$J,358.3,29915,2)
 ;;=^5003509
 ;;^UTILITY(U,$J,358.3,29916,0)
 ;;=A81.00^^120^1518^8
 ;;^UTILITY(U,$J,358.3,29916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29916,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,29916,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,29916,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,29917,0)
 ;;=A81.09^^120^1518^7
 ;;^UTILITY(U,$J,358.3,29917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29917,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,29917,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,29917,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,29918,0)
 ;;=A81.2^^120^1518^29
 ;;^UTILITY(U,$J,358.3,29918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29918,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,29918,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,29918,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,29919,0)
 ;;=F01.51^^120^1518^32
 ;;^UTILITY(U,$J,358.3,29919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29919,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,29919,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,29919,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,29920,0)
 ;;=G30.9^^120^1518^4
 ;;^UTILITY(U,$J,358.3,29920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29920,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,29920,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,29920,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,29921,0)
 ;;=G31.01^^120^1518^27
 ;;^UTILITY(U,$J,358.3,29921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29921,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,29921,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,29921,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,29922,0)
 ;;=G94.^^120^1518^6
 ;;^UTILITY(U,$J,358.3,29922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29922,1,3,0)
 ;;=3^Brain D/O in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,29922,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,29922,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,29923,0)
 ;;=G31.83^^120^1518^17
 ;;^UTILITY(U,$J,358.3,29923,1,0)
 ;;=^358.31IA^4^2
